Cancer genome medicine or precision cancer medicine is to provide the optimal treatment based on genetic mutations in cancer tissue. This field holds the promise of personalized medical care that is appropriate to the genomic information of each patient’s cancer. Hopes are high that this could be “a dream cancer treatment.”
Cancer genome medicine is being promoted in developed countries around the world. On the other hand, challenges remain: there is a shortage of specialists with knowledge of advanced genome information, while selecting therapeutic agents is difficult.
Fujitsu is advancing the “Healthy Living” initiative to work towards a world that enriches the life experience of everyone and continues to expand their potential.